within Pharmacolibrary.Drugs.N_NervousSystem.N02A_Opioids.N02AA01_Morphine;

model Morphine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.883333333333333e-05,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.021,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.124,
    k12 = 4.1666666666666665e-05,
    k21 = 4.1666666666666665e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Morphine</td></tr><tr><td>ATC code:</td><td>N02AA01</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>21</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.13</td><td>L/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Morphine is a potent opioid analgesic derived from opium and is primarily used for the relief of moderate to severe pain. It acts as an agonist at the mu-opioid receptor and is widely used in both acute and chronic pain management, including post-surgical, cancer, and palliative care settings. Morphine is an approved drug and is currently utilized globally for its analgesic properties.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult subjects after intravenous administration.</p><h4>References</h4><ol><li><p>Lugo, RA, &amp; Kern, SE (2002). Clinical pharmacokinetics of morphine. <i>Journal of pain &amp; palliative care pharmacotherapy</i> 16(4) 5–18. DOI:<a href=\"https://doi.org/10.1080/j354v16n04_02\">10.1080/j354v16n04_02</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14635822/\">https://pubmed.ncbi.nlm.nih.gov/14635822</a></p></li><li><p>Brokjær, A, et al., &amp; Drewes, AM (2015). Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation study. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 68 78–86. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2014.12.004\">10.1016/j.ejps.2014.12.004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25486331/\">https://pubmed.ncbi.nlm.nih.gov/25486331</a></p></li><li><p>Ihmsen, H, et al., &amp; Jeleazcov, C (2021). Pharmacokinetics of Morphine and Morphine-6-Glucuronide During Postoperative Pain Therapy in Cardiac Surgery Patients. <i>European journal of drug metabolism and pharmacokinetics</i> 46(2) 249–263. DOI:<a href=\"https://doi.org/10.1007/s13318-020-00663-z\">10.1007/s13318-020-00663-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33547559/\">https://pubmed.ncbi.nlm.nih.gov/33547559</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N02AA01 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Morphine;
